Plovamer acetate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePlovamer acetate
Drug Alias NamePI-2301CO-14
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMajor histocompatibility complex II modulators
TargetsMajor histocompatibility complex II
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-Remitting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[17] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPeptimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmd Serono Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis, Relapsing-Remitting

Other Information

ATC CodeN/A
Related LinksKEGG